Recall Radar
All recallsMedicine & devices

Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPLE NOT FOR SALE, NDC 50222-350-91; b) 2 x Single dose Autoinjectors, NDC 50222-3…

Lack of Assurance of Sterility: due to the presence of particulate matter in one unit from the lot, which lab tests have identified as wool fiber.

Class II Medicine & devices FDA March 4, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
LEO PHARMA INC — Madison, NJ
Severity
Class II — moderate
Reported
March 4, 2026
Quantity
11,407 units
Recall number
D-0339-2026
Status
Ongoing
Source
FDA

Where it went

Nationwide in the USA

Other medicine & devices recalls

See every current recall on the live dashboard →